Suchergebnisse - "Onal, Cem"

PubPharm (285)

1

The effect of dose-escalation radiotherapy with simultaneous-integrated-boost on the use of short-term androgen deprivation therapy in patients with intermediate risk prostate cancer

enthalten in: The Prostate | 2024

von Onal, C. | Guler, O. | Erbay, G. | +1

2

Partially Ablative Body Radiotherapy (PABR) : A novel approach for palliative radiotherapy of locally advanced bulky unresectable sarcomas. In regard to Yu et al

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2024

von Elmali, A. | Topkan, E. | Onal, C.

3

Can nomograms accurately predict lymph node metastasis in high-risk prostate cancer patients receiving definitive radiotherapy in the PSMA-PET/CT era?-Time to burry the hatchet

enthalten in: Urologic oncology | 2024

von Onal, C. | Elmali, A. | Guler, O.

4

Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients - A closer inspection will improve your vision

enthalten in: Clinical and translational radiation oncology | 2024

von Onal, C. | Elmali, A. | Guler, O.

5

Re : Pawel Rajwa, Daniele Robesti, Michael Chaloupka, et al. Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.006

enthalten in: European urology oncology | 2024

von Onal, C. | Elmali, A. | Cem Guler, O.

6

Long-term assessment of clinical parameters and positron emission tomography parameters in predicting recurrence in uterine cervical cancer patients receiving definitive chemoradiotherapy

enthalten in: Nuclear medicine communications | 2024

von Onal, C. | Guler, O. | Torun, N. | +1

7

The impact of margin reduction on radiation dose distribution of ultra-hypofractionated prostate radiotherapy utilizing a 1.5-T MR-Linac

enthalten in: Journal of applied clinical medical physics | 2024

von Onal, C. | Efe, E. | Bozca, R. | +3

8

The impact of margin reduction on radiation dose distribution of ultra‐hypofractionated prostate radiotherapy utilizing a 1.5‐T MR‐Linac

enthalten in: Journal of Applied Clinical Medical Physics | 2024

von Onal, C. | Efe, E. | Bozca, R. | +3

9

The effect of dose‐escalation radiotherapy with simultaneous‐integrated‐boost on the use of short‐term androgen deprivation therapy in patients with intermediate risk prostate cancer

enthalten in: The Prostate | 2024

von Onal, C. | Guler, O. | Erbay, G. | +1

10

The significance of metabolic response to neoadjuvant androgen deprivation therapy detected with [68Ga]Ga-PSMA-11-PET/CT in high-risk prostate cancer patients treated with definitive radiotherapy

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Onal, C. | Guler, O. | Torun, N. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[29]